Quipt Home Medical Corp. (NASDAQ:QIPT) Shares Purchased by Royce & Associates LP

Royce & Associates LP increased its holdings in Quipt Home Medical Corp. (NASDAQ:QIPT - Free Report) by 12.1% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,982,089 shares of the company's stock after acquiring an additional 213,300 shares during the quarter. Royce & Associates LP owned approximately 4.60% of Quipt Home Medical worth $6,045,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the business. State Street Corp increased its stake in Quipt Home Medical by 1.0% in the 3rd quarter. State Street Corp now owns 621,388 shares of the company's stock valued at $1,814,000 after buying an additional 6,317 shares during the period. Jane Street Group LLC increased its stake in Quipt Home Medical by 28.5% in the 3rd quarter. Jane Street Group LLC now owns 41,926 shares of the company's stock valued at $122,000 after buying an additional 9,290 shares during the period. JPMorgan Chase & Co. increased its stake in Quipt Home Medical by 68.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 30,403 shares of the company's stock valued at $89,000 after buying an additional 12,383 shares during the period. Atom Investors LP acquired a new position in Quipt Home Medical in the 3rd quarter valued at $51,000. Finally, XTX Topco Ltd acquired a new position in Quipt Home Medical in the 3rd quarter valued at $54,000. 42.85% of the stock is owned by institutional investors and hedge funds.

Quipt Home Medical Price Performance

Shares of NASDAQ:QIPT traded up $0.06 on Friday, reaching $2.37. 488,715 shares of the company were exchanged, compared to its average volume of 195,258. The company has a 50-day moving average of $2.77 and a 200-day moving average of $2.75. The company has a current ratio of 1.22, a quick ratio of 0.87 and a debt-to-equity ratio of 0.74. The firm has a market cap of $102.13 million, a price-to-earnings ratio of -13.94 and a beta of 0.61. Quipt Home Medical Corp. has a 1-year low of $2.23 and a 1-year high of $4.43.

Remove Ads

Quipt Home Medical (NASDAQ:QIPT - Get Free Report) last announced its quarterly earnings results on Monday, February 10th. The company reported ($0.03) earnings per share (EPS) for the quarter. Quipt Home Medical had a negative net margin of 2.90% and a negative return on equity of 6.70%. Equities analysts forecast that Quipt Home Medical Corp. will post -0.05 earnings per share for the current fiscal year.

Insider Activity

In related news, VP Patrick Dennis Gamble purchased 17,000 shares of the business's stock in a transaction dated Thursday, December 26th. The stock was acquired at an average price of $2.45 per share, for a total transaction of $41,650.00. Following the acquisition, the vice president now directly owns 40,057 shares of the company's stock, valued at $98,139.65. This trade represents a 73.73 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 13.40% of the company's stock.

Quipt Home Medical Profile

Quipt Home Medical Corp., through its subsidiaries, engages in the provision of durable and home medical equipment and supplies in the United States. The company offers nebulizers, oxygen concentrators, and CPAP and BiPAP units; traditional and non-traditional durable medical respiratory equipment and services; non-invasive ventilation equipment, supplies, and services; and engages in the rental of medical equipment.